Susquehanna International Group, LLP Agios Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 19,220 shares of AGIO stock, worth $662,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,220

Previous 11,930 61.11%

Holding current value

$662,321

Previous $514,000 65.95%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $300,275 - $362,458	7,290 Added 61.11%	19,220 $853,000
Q2 2024 Aug 15, 2024	SELL	$27.55 - $48.83 $276,243 - $489,618	-10,027 Reduced 45.67%	11,930 $514,000
Q1 2024 May 07, 2024	SELL	$21.32 - $34.81 $12,216 - $19,946	-573 Reduced 2.54%	21,957 $642,000
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $72,471 - $89,019	3,629 Added 19.2%	22,530 $501,000
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $83,018 - $96,037	-3,408 Reduced 15.28%	18,901 $467,000
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $2.09 Million - $2.85 Million	-97,589 Reduced 81.39%	22,309 $631,000
Q1 2023 May 16, 2023	BUY	$21.74 - $30.93 $2.02 Million - $2.88 Million	92,959 Added 345.07%	119,898 $2.75 Million
Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $642,926 - $816,809	-25,914 Reduced 49.03%	26,939 $756,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $1.03 Million - $1.8 Million	52,853 New	52,853 $1.5 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $783,911 - $1.02 Million	-29,382 Reduced 35.81%	52,659 $1.53 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $3.28 Million - $5.52 Million	-110,974 Reduced 57.5%	82,041 $2.7 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $22,511 - $31,242	-537 Reduced 0.28%	193,015 $8.91 Million
Q2 2021 Aug 11, 2021	BUY	$52.06 - $61.27 $9.57 Million - $11.3 Million	183,914 Added 1908.22%	193,552 $10.7 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $1.82 Million - $2.37 Million	-41,216 Reduced 81.05%	9,638 $498,000
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $726,169 - $1.02 Million	21,866 Added 75.43%	50,854 $2.2 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $3 Million - $4.96 Million	-88,664 Reduced 75.36%	28,988 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $1.36 Million - $2.11 Million	39,453 Added 50.45%	117,652 $6.29 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $1.14 Million - $1.94 Million	-36,145 Reduced 31.61%	78,199 $2.78 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $5.5 Million - $9.24 Million	-182,702 Reduced 61.51%	114,344 $5.46 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $5.63 Million - $8.61 Million	173,616 Added 140.66%	297,046 $9.62 Million
Q2 2019 Aug 16, 2019	BUY	$46.17 - $68.1 $232,881 - $343,496	5,044 Added 4.26%	123,430 $6.16 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $2.61 Million - $3.85 Million	56,544 Added 91.43%	118,386 $5.91 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $2.15 Million - $3.84 Million	50,203 Added 431.33%	61,842 $2.85 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $1.2 Million - $1.64 Million	-16,428 Reduced 58.53%	11,639 $980,000
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $1.6 Million - $2.32 Million	-26,784 Reduced 48.83%	28,067 $2.3 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $1.12 Million - $1.56 Million	-21,554 Reduced 28.21%	54,851 $3.14 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $4.19 Million - $5.13 Million	76,405	76,405 $5.1 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Agios Pharmaceuticals, Inc. Transaction History